Drugs / IDP-115
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT00667173 | Nov 2007 → Jul 2008 | rosacea | Dow Pharmaceutical Sciences | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | IDP-115 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00667173 ↗ |
| Route | Topical | “Topical application for 12 weeks” NCT00667173 ↗ |